期刊文献+

曲古霉素A对人宫颈癌Hela细胞增殖及凋亡的影响

Effects of Trichostatin a on Proliferation and Apoptosis in Human Cervical Carcinoma Cell Line Hela
下载PDF
导出
摘要 目的:探讨组蛋白乙酰化酶抑制剂曲古霉素A(TSA)对人宫颈癌Hela细胞增殖和调亡的作用及其机制。方法:不同浓度的TSA处理Hela细胞,应用Western blot法检测细胞内组蛋白H4(Ac-H4)乙酰化水平,荧光定量PCR方法检测p21mRNA表达,MTT法检测细胞增殖,流式细胞仪检测细胞凋亡率。结果:随着TSA浓度增加,人宫颈癌Hela细胞内Ac-H4乙酰化水平增加(P<0.05),p21mRNA表达增加(P<0.05),细胞增值率减少(P<0.05),细胞凋亡率增加(P<0.05)。结论:TSA通过提高组蛋白乙酰化水平,增加p21基因表达,抑制人宫颈癌Hela细胞的增殖和诱导细胞凋亡,且呈浓度依赖性。 Objective :To investigate the effects of trichostatin A (TSA) on proliferation and apoptosis in human cervical carcinoma cell line Hela and the possible mechanism. Methods:Hela cells were treated with different concentration of histone deacetylase inhibitor TSA. Western blot was used to detect the acetyl level of histone H4 and real time PCR was used to detect mRNA of the p21 gene. Furthermore,cell growth was e- valuated by MI-I assay and cell apoptosis rate was tested by flow cytometry. Results:After treated with TSA,the acetyl level of histone H4 and the expression of mRNA of the p21 gene both increased in Hela cells significantly( P 〈0.05). Meanwhile, the cellular growth activity decreased and cell apoptosis increased (P 〈 0.05). Conclusions:The TSA could effectively inhibit the cellular proliferation and induce apoptosis of cervi- cal carcinoma cells by increasing the acetyl level of histone and by enhancing the p 21 gene expression,and there are concentration dependent.
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2012年第12期1023-1025,共3页 Journal of Practical Obstetrics and Gynecology
关键词 宫颈癌 曲古霉素A 组蛋白乙酰化酶 增殖 凋亡 Cervical carcinoma Trichostatin A Histone deacetylase Proliferation Apoptosis
  • 相关文献

参考文献10

  • 1Laird PW. Cancer epigenetices [ J ]. Hum Mol Cenet, 2005,14 (1) : 65 - 76,.
  • 2Mufioz N. Human papillomavirus and cancer: the epidemiological evi- dence [ J ]. J Clin Virol,2000,19 ( 1/2 ) : 1 - 5.
  • 3Duefias-Conzu|ez A, Lizano M, Candelaria M,et al. Epigenetics of cer- vical cancer, an overview and therapeutic perspectives[ J]. Mol Canc- er,2005,25 (4) :38.
  • 4Chavez-Blanco A, Segura-Parcheco B, Perez-Cadenas E,et al. Histone acethylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer:a phase I study[ J]. Mol Cancer,2005,4(1 ) :22.
  • 5Yugawa T, Kiyomo T. Molecular mechanisms of cervical carcinogene- sis by high-risk human papillomaviruses:novel function of E6 and E7 oncoproteins[ J]. Rev Med Virol,2009,19( 1 ) :97 - 113.
  • 6Hagelkruys A, Sawicka A, Selser C, et al. The biology of HDAC in cancer; the nuclear and epigenetic components[ J]. Handb Exp Phar- maco1.2011.206 : 13 - 37.
  • 7Pratap J, Akech J, Wixted JJ, et al. Potentiol anti-cancer activity of N-hydroxy-7-( 2-naphthyhhio ) heptanomide ( HNHA ), a histone deacetylase inhibitor,against breast cancer both in vitro and in vivo [ J ]. Mol Cancer Ther,2010,9 ( 12 ) :3210 - 3220.
  • 8Liu Y, Salvador LA, Byeon S, et al. Anticolon cancer activity of lar- gazole, a marine-derived tunable histone deacetylase inhibitor [ J ]. J Pharmacol Exp Ther,2010,335 ( 2 ) :351 - 361.
  • 9Platta CS, Greenblatt DY, Kunnimalaiyaan M ,,et al. The HDAC inhib- itor trichostatin A inhibits growth of small cell lung cancer cells [ J ]. Surrg Res,2007,142 (2) :219 - 226.
  • 10Li H, Wu X. Histone deacetylase inhibitor, trichostatin A, actives p21WAF1/CIP1 expression through downregulation of c-myc and re- lease of the expression of c-myc from the promoter in human cervical cancer cells [ J ]. Biochem Biophys Res Commun, 2004,324 ( 2 ) : 860 - 867.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部